122 related articles for article (PubMed ID: 3293416)
1. Probucol Quantitative Regression Swedish Trial: new angiographic technique to measure atheroma volume of the femoral artery.
Erikson U; Nilsson S; Stenport G
Am J Cardiol; 1988 Jul; 62(3):44B-47B. PubMed ID: 3293416
[TBL] [Abstract][Full Text] [Related]
2. Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol Quantitative Regression Swedish Trial (PQRST): a status report.
Walldius G; Carlson LA; Erikson U; Olsson AG; Johansson J; Mölgaard J; Nilsson S; Stenport G; Kaijser L; Lassvik C
Am J Cardiol; 1988 Jul; 62(3):37B-43B. PubMed ID: 3293415
[TBL] [Abstract][Full Text] [Related]
3. The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST).
Walldius G; Erikson U; Olsson AG; Bergstrand L; Hådell K; Johansson J; Kaijser L; Lassvik C; Mölgaard J; Nilsson S
Am J Cardiol; 1994 Nov; 74(9):875-83. PubMed ID: 7977117
[TBL] [Abstract][Full Text] [Related]
4. Changes in atheroma volume estimated from digitized femoral arteriograms.
Nilsson S; Erikson U
Acta Radiol; 1990 May; 31(3):249-57. PubMed ID: 2201327
[TBL] [Abstract][Full Text] [Related]
5. Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A Probucol Quantitative Regression Swedish Trial (PQRST) Report.
Johansson J; Olsson AG; Bergstrand L; Elinder LS; Nilsson S; Erikson U; Mölgaard J; Holme I; Walldius G
Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1049-56. PubMed ID: 7627695
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of quantitative arteriographic assessment of atherosclerosis in the femoral artery.
Bergstrand L; Erikson U; Holme I; Johansson J; Olsson AG; Mølgaard J; Nilsson S; Stenport G; Walldius G
Acta Radiol; 1993 Nov; 34(6):612-7. PubMed ID: 8240898
[TBL] [Abstract][Full Text] [Related]
7. The role of lipids and antioxidative factors for development of atherosclerosis. The Probucol Quantitative Regression Swedish Trial (PQRST).
Walldius G; Regnström J; Nilsson J; Johansson J; Schäfer-Elinder L; Moelgaard J; Hådell K; Olsson AG; Carlson LA
Am J Cardiol; 1993 Feb; 71(6):15B-19B. PubMed ID: 8434556
[TBL] [Abstract][Full Text] [Related]
8. The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis.
Regnström J; Walldius G; Nilsson S; Elinder LS; Johansson J; Mölgaard J; Holme I; Olsson AG; Nilsson J
Atherosclerosis; 1996 Sep; 125(2):217-29. PubMed ID: 8842353
[TBL] [Abstract][Full Text] [Related]
9. Femoral and coronary atherosclerosis in patients with hyperlipidaemia. Arteriographic findings correlated to clinical and biochemical parameters.
Bergstrand L
Acta Radiol Suppl; 1994; 392():1-27. PubMed ID: 8184697
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of atherosclerosis in femoral arteriography with ECG gated exposures.
Nilsson S; Berglund I; Bylund H; Erikson U; Helmius G; Hemmingsson A; Holme I; Stenport G; Walldius G
Acta Radiol; 1988; 29(3):311-5. PubMed ID: 2968100
[TBL] [Abstract][Full Text] [Related]
11. Combined effects of cholestyramine and probucol on regression of atherosclerosis in rhesus monkey aortas.
Wissler RW; Vesselinovitch D
Appl Pathol; 1983; 1(2):89-96. PubMed ID: 6678159
[TBL] [Abstract][Full Text] [Related]
12. Image operations in quantification of atherosclerosis from digitized angiograms.
Berglund I; Bengtsson E; Erikson U; Högman N; Nilsson S
Comput Methods Programs Biomed; 1991 May; 35(1):1-10. PubMed ID: 1879130
[TBL] [Abstract][Full Text] [Related]
13. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.
Kita T; Nagano Y; Yokode M; Ishii K; Kume N; Ooshima A; Yoshida H; Kawai C
Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5928-31. PubMed ID: 3475709
[TBL] [Abstract][Full Text] [Related]
14. Repeated measurements over time: statistical analysis of the angiographic outcomes in the Probucol Quantitative Regression Swedish Trial (PQRST).
Holme I; Malmaeus I; Olsson AG; Nilsson S; Walldius G
Clin Trials Metaanal; 1993 Mar; 28(2):95-108. PubMed ID: 10148446
[TBL] [Abstract][Full Text] [Related]
15. Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis.
Glueck CJ
Ann Intern Med; 1982 Apr; 96(4):475-82. PubMed ID: 7039445
[TBL] [Abstract][Full Text] [Related]
16. The probucol experience: a review of the past and a look at the future.
Schwartz CJ
Am J Cardiol; 1988 Jul; 62(3):1B-5B. PubMed ID: 3293414
[No Abstract] [Full Text] [Related]
17. Correlation between computer-assisted femoral arteriography and physiological tests in hypercholesterolaemic patients: a methodological study with special reference to clinical trials.
Nilsson S; Kaijser L; Erikson U; Johansson J; Walldius G
Clin Physiol; 1992 Jan; 12(1):53-68. PubMed ID: 1541084
[TBL] [Abstract][Full Text] [Related]
18. Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia.
Heel RC; Brogden RN; Speight TM; Avery GS
Drugs; 1978 Jun; 15(6):409-28. PubMed ID: 350557
[No Abstract] [Full Text] [Related]
19. Angiographic assessment of atherosclerosis during lipid-lowering therapy.
Blankenhorn DH
Cardiology; 1989; 76 Suppl 1():75-9; discussion 79-82. PubMed ID: 2653625
[No Abstract] [Full Text] [Related]
20. Hypercoagulable state in the Watanabe heritable hyperlipidemic rabbit, an animal model for the progression of atherosclerosis. Effect of probucol on coagulation.
Mori Y; Wada H; Nagano Y; Deguchi K; Kita T; Shirakawa S
Thromb Haemost; 1989 Feb; 61(1):140-3. PubMed ID: 2749587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
